For licensed clinics onlyRefrigerated lines shipped cold
1-800-630-9757Open hoursMonday to Friday, 9am to 6pm ETBook a call with MWS

Signs Nexplanon Is Wearing Off and What to Check in Clinic

Signs Nexplanon Is Wearing Off and What to Check in Clinic

No symptom reliably tells a patient that her etonogestrel implant has stopped working. The only dependable marker of remaining contraceptive cover is the documented insertion date, read against the labeled duration of use. Bleeding changes, cramping, acne, or mood shifts are common throughout the life of the implant and do not track falling hormone release in any usable way.

That single point resolves most of the questions clinics field about the signs Nexplanon is wearing off. It also redirects the visit toward what actually matters: confirming the device is in place, checking the replacement date, reviewing interacting medications, and testing when pregnancy is plausible. The sections below work through that sequence in the order a clinician would.

The Short Version

  • Duration is clock-based, not symptom-based. Insertion date governs replacement, not how the patient feels.
  • Bleeding patterns are unpredictable from day one. A change in year three means little on its own.
  • Three scenarios warrant real concern: a non-palpable implant, enzyme-inducing drug therapy, and an overdue device.
  • Pregnancy symptoms warrant a test, with ectopic pregnancy kept in the differential.
  • Fertility returns quickly after removal, so bridging contraception should be discussed before the device comes out.

What Patients Mean by Signs Nexplanon Is Wearing Off

Patients usually describe one of four changes: periods returning after months of amenorrhea, heavier or longer bleeding, new cramping that feels ovulatory, or shifts in acne, libido, and mood. Each is plausible as a hormonal effect. None has been validated as a marker of waning efficacy.

The prescribing information describes a wide and shifting range of bleeding patterns across the whole period of use. Roughly one in five users report no bleeding at all, while infrequent bleeding is the single most common pattern. Prolonged or frequent bleeding also occurs and is the leading reason users ask for early removal. Importantly, the pattern an individual settles into in the first months does not predict what happens later, and a change does not signal that the device has run out.

Hormone release does decline. Etonogestrel delivery is highest in the first weeks after insertion and falls gradually across the labeled period. That decline is built into the dosing design, and serum concentrations are intended to stay above the level associated with ovulation suppression for the full labeled duration. In other words, falling release is expected and is not itself evidence of failure.

Why it matters: Treating symptom reports as proof of expiry leads to unnecessary early removals and avoidable gaps in cover.

How Long the Implant Is Labeled to Last

The single-rod etonogestrel 68 mg implant is approved in the United States for prevention of pregnancy for up to three years, after which the device should be removed and may be replaced. The three-year clock begins at insertion, not at the point the patient first noticed a change in bleeding. Published failure rates are consistently below one pregnancy per 100 users per year, placing it among the most effective reversible methods available.

There is published evidence examining contraceptive effect beyond three years, and some professional guidance acknowledges it. Extended use past the labeled interval is off-label in the US. If a clinic discusses it, the conversation should be documented as off-label, grounded in current guidance, and never presented as the approved duration. Full labeling for the product is available through the FDA’s official labeling repository.

Is there such a thing as expired implant symptoms?

No. A device past its replacement date does not produce a recognizable symptom cluster. Patients searching for expired implant symptoms are usually describing ordinary bleeding variation, or a pregnancy that has already occurred for a separate reason. The practical answer in clinic is a date check and, where relevant, a pregnancy test.

Note that two different expiry concepts get confused. The carton carries a sterile-product expiration date that governs whether a clinic may insert that unit. The three-year interval governs how long an inserted device remains labeled for use. They are unrelated, and both belong in the chart.

When Contraceptive Efficacy Is Genuinely in Question

A small number of situations deserve active investigation rather than reassurance. These are the real-world answers when a patient asks how to know if the implant is not working.

  • The implant cannot be palpated. This raises the possibility of deep placement, migration, or a failed insertion.
  • Enzyme-inducing medication was started. Serum etonogestrel can fall during concurrent therapy.
  • The device is past its replacement date. Cover should not be assumed beyond the labeled interval.
  • Insertion timing was unclear. Backup for the first seven days is required unless inserted within the first five days of a cycle, or under the switching rules in the labeling.
  • Pregnancy symptoms are present. Test first and interpret the result before adjusting anything else.

Drug interactions worth flagging

Strong cytochrome P450 3A4 inducers can lower progestin concentrations. Rifampin, several older anticonvulsants, certain antiretrovirals, bosentan, and St. John’s wort are the commonly cited examples. The labeling advises counseling on a backup or alternative method during use of an interacting drug and for a period afterward. The CDC’s US Medical Eligibility Criteria for Contraceptive Use gives category guidance for these combinations and should be checked against the current edition rather than memory.

Body weight is a frequent question. Labeling notes that serum etonogestrel concentrations are inversely related to body weight and decline over time, but it does not direct a shortened replacement interval. Avoid telling patients that a higher weight means the implant has worn off early.

The non-palpable implant

If the rod cannot be felt, do not remove by exploration and do not assume it was never inserted. Localization comes first. High-frequency ultrasound by an operator familiar with the device is the usual first step. The implant contains barium sulfate and is radiopaque, so two-dimensional radiography of the arm is a reasonable alternative when ultrasound is unavailable or inconclusive. MRI and etonogestrel serum assay are later options. The manufacturer maintains clinical support for localization and removal, and referral to a trained remover is appropriate when imaging is ambiguous or the device sits near neurovascular structures. Until placement is confirmed, the patient should use an additional method.

Confirming Status and Ruling Out Pregnancy

Work through a fixed sequence so nothing is skipped. First, retrieve the insertion date, arm, and lot from the record or the patient card. Second, palpate the implant and document that it was felt along its full length. Third, review the medication list for inducers started since insertion. Fourth, perform a urine pregnancy test if there is any plausible exposure, late or absent bleeding in a previously regular user, or new pelvic pain.

A positive test in a patient with an implant in situ requires prompt assessment, including consideration of ectopic pregnancy. Pelvic pain with a positive test is an urgent evaluation, not a routine follow-up. If an intrauterine pregnancy is confirmed and continues, labeling directs removal of the implant. Serum etonogestrel measurement is rarely useful for routine reassurance and is mainly reserved for localization problems or medicolegal questions.

Counseling Points That Reduce Repeat Visits

Set expectations at insertion and most of these consultations never happen. Tell patients plainly that bleeding will be unpredictable, that patterns can change at any point, and that no sensation signals the end of effectiveness. Give the replacement month in writing, on a card and in the after-visit summary, and encourage a phone reminder set by the patient in the room.

Be equally direct about what should prompt contact: a rod that can no longer be felt, a new prescription for an interacting medicine, pelvic pain, or a positive pregnancy test. Framing the discussion this way answers the underlying question behind most searches about the signs Nexplanon is wearing off without implying that symptoms carry diagnostic weight.

Removal, Replacement, and Return of Fertility

Removal is a minor procedure performed under local anesthetic through a small incision at the distal end of the rod. When a patient wants to continue the method, a new implant may be placed in the same arm, through the same incision, along the same track described in the labeling. That approach keeps scarring and chair time down.

Fertility returns rapidly. Serum etonogestrel becomes undetectable within about a week of removal, and ovulation can resume soon after. Patients who are not seeking pregnancy need a method in place at the point of removal, not a week later. For those switching to another method, the CDC’s Selected Practice Recommendations set out the timing and backup rules for each transition.

Stock Handling, Documentation, and Sourcing

Implant stock is simple to manage but easy to get wrong at the margins. Store units at controlled room temperature within the range printed on the carton, away from direct heat. Rotate by expiration date and check the sterile package before every insertion. Record the lot number and carton expiry in the procedure note alongside the arm used, the insertion site, confirmation of palpation after placement, and the date replacement is due.

Clinics that stock multiple product lines through a single account should keep contraceptive devices on the same lot-tracking discipline as injectables. Med Wholesale Supplies is a wholesale supplier of aesthetic, orthopedic and medical products to clinics, hospitals and medical professionals, operating since 2013.

Clinic Checklist for the Patient Who Thinks the Implant Has Stopped Working

  • Confirm the insertion date from the chart, card, or prior clinic.
  • Palpate both ends of the rod and document the finding.
  • Image before exploring if the device cannot be felt.
  • Screen the medication list for enzyme-inducing drugs added since insertion.
  • Test for pregnancy where exposure is plausible or bleeding has stopped unexpectedly.
  • Escalate pelvic pain with a positive test for same-day assessment.
  • Book replacement before the labeled interval ends, with bridging cover agreed if removal will be delayed.

Handled this way, a worried patient leaves with a date rather than a theory, and the clinic has a defensible record of what was checked. Product facts above follow current US labeling and federal contraceptive guidance; confirm specifics against the edition in force at the time of care.

This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.

Frequently asked questions

How do you know if Nexplanon is not working?

There is no symptom that confirms loss of effectiveness. The practical checks are the insertion date, whether the rod can still be palpated, and whether an enzyme-inducing medication has been started. A pregnancy test answers the question directly when exposure is plausible or when bleeding stops unexpectedly in a previously regular user. Bleeding changes alone are not informative, because patterns shift throughout the life of the implant. If the device cannot be felt, treat effectiveness as unconfirmed, advise an additional method, and arrange imaging to locate it.

Can the implant stop working before its replacement date?

Early loss of contraceptive cover is uncommon but possible in specific situations. A device that was never properly inserted provides no protection, which is why palpation immediately after placement is documented. Deep placement or migration can complicate both localization and removal. Concurrent treatment with strong CYP3A4 inducers, such as rifampin, several older anticonvulsants, or St. John’s wort, can reduce progestin concentrations, and labeling advises a backup or alternative method during and after that therapy. Outside these scenarios, the labeled interval holds, and symptoms are not evidence of early failure.

How long is the etonogestrel implant approved to last?

In the United States, the single-rod etonogestrel 68 mg implant is approved for prevention of pregnancy for up to three years, counted from the date of insertion. The device should then be removed and may be replaced at the same visit. Published research has examined effect beyond three years and some professional guidance acknowledges that evidence, but use past the labeled interval is off-label in the US. Any such discussion should be documented as off-label and based on current guidance rather than presented as the approved duration of use.

Are there symptoms of an expired implant?

No recognizable symptom pattern indicates that an implant has passed its replacement date. Patients describing new cramping, returning periods, acne, or mood changes are usually experiencing ordinary variation that occurs at any point during use. The answer in clinic is a date check rather than symptom interpretation. Two separate expiry concepts should be kept distinct in the record: the sterile carton’s expiration date, which determines whether a unit may be inserted, and the three-year interval, which determines how long an inserted device remains labeled for use.

What should a clinic do when the implant cannot be palpated?

Stop before attempting removal and localize first. High-frequency ultrasound performed by someone familiar with the device is the usual initial step. Because the implant contains barium sulfate and is radiopaque, two-view radiography of the arm is a reasonable alternative when ultrasound is unavailable or inconclusive. MRI and serum etonogestrel measurement are later options. Advise an additional contraceptive method until placement is confirmed, document every imaging attempt, and refer to a clinician trained in deep removal if the device lies near neurovascular structures or remains unlocated.

How quickly does fertility return after removal?

Return of fertility is rapid. Serum etonogestrel typically becomes undetectable within about a week of removal, and ovulation can resume shortly afterward. For patients not planning pregnancy, a new method should be in place at the time of removal rather than started later. If a new implant is being placed, it can usually go in through the same incision along the track described in the labeling. For transitions to pills, injectables, or an intrauterine device, follow current federal practice recommendations for timing and any backup required.

Frequently asked questions

Not by themselves. Spotting, heavier bleeding, lighter bleeding, or no bleeding at all can occur during implant use and near the replacement window. These patterns are nonspecific and do not prove loss of contraceptive effect. A clinic review should focus on the documented insertion date, the current approved duration in the prescribing information, interaction risk, pregnancy symptoms, and other possible gynecologic causes before drawing conclusions.

Clinically, the safer approach is to treat the current labeled duration as the operative limit rather than waiting for a sudden symptom change. The implant does not usually announce end-of-use with a clear physical sign. Online discussions may mention different timelines, but routine practice should follow the latest prescribing information and local protocol. If a device is nearing the documented replacement date, plan review and replacement proactively rather than assuming ongoing protection beyond that window.

The 7-day rule refers to when backup contraception may be needed after insertion or replacement, depending on cycle timing and method transition. It is not a sign that the implant is wearing off. For clinics, the practical point is to use current CDC and label-backed guidance, document what method was being used before the implant, and record whether temporary backup advice was given after the visit.

Yes, some medications and herbal products can lower etonogestrel levels. Enzyme-inducing treatments are the main concern, so a recent medication change can matter even if the implant is still within its expected use window. Interaction review should be part of any assessment for suspected reduced reliability. If risk is identified, clinics should document the exposure, review current guidance, and clarify whether backup contraception or a different contraceptive plan is needed.

Urgent evaluation is appropriate when pregnancy is suspected and there is severe lower abdominal pain, fainting, or a positive test with pain, because ectopic pregnancy must be considered. Prompt review is also warranted if the implant cannot be felt, if there is significant arm pain or swelling, or if bleeding is heavy enough to raise concern for instability or another acute condition. Those situations go beyond routine symptom monitoring and need a defined escalation pathway.

Key documentation points include the insertion date, product identity if available, whether the rod is palpable, current medications and herbal products, reported symptoms, pregnancy risk review, and the replacement or removal plan. It is also useful to record any counseling on backup contraception after replacement, plus the rationale if guidance beyond routine labeling is being considered. Good documentation turns a vague symptom question into a clear timeline and risk assessment.

About this article

Written by

Med Wholesale Supplies Editorial Team

The Med Wholesale Supplies editorial team writes practical, clinician-facing guides on aesthetic injectables, orthopaedic and medical supplies, product selection and clinic workflow, sourced from product documentation, regulators and peer-reviewed literature.

Medical disclaimerThe information published on Med Wholesale Supplies is provided for informational purposes only and should not be considered medical advice, diagnosis, or treatment guidance. Healthcare decisions should always be made in consultation with a licensed physician, pharmacist, or other qualified healthcare professional. If you are experiencing a medical emergency, call 911 or seek emergency care immediately.

Editorial policyMed Wholesale Supplies is committed to publishing clear, accurate, and medically reviewed content for readers and healthcare audiences. Our editorial standards are intended to support responsible, evidence-informed communication and a high level of content quality. Please visit our Editorial Standards page to learn more about how our content is developed and reviewed.

From our catalog

Related products

Shop all products

Keep reading

More articles on this topic

All articles